Stacks of US dollar banknotes bundled and stored in a metal briefcase
Reading Time: 2 minutes
Middle East Conflict
*According to sources, delegations from the United States and Iran will hold negotiations in Islamabad, Pakistan, later this week.
*The U.S. State Department issued a statement after the tripartite Washington talks between Israel, Lebanon and the United States, saying that the participants had a fruitful discussion on various measures to promote direct negotiations between Israel and Lebanon.
Industrial Economy
*The General Office of the State Council issued on April 14 the “Several Opinions on Improving the Mechanism for Drug Price Formation”, proposing 14 measures, including optimizing the initial pricing mechanism for newly launched drugs such as innovative drugs, leveraging the guiding role of medical insurance payment standards in drug price formation, guiding pharmacies to set reasonable drug retail prices, and strengthening the supply guarantee and price stabilization of drugs in shortage.
*SK Hynix plans to reduce its shipments of sixth-generation High Bandwidth Memory (HBM4) to NVIDIA this year by approximately 20% to 30% compared to the original plan, reportedly due to difficulties NVIDIA is facing in mass-producing its Vera Rubin chips.
International Relationship
*President Xi Jinping met with Khalid, Crown Prince of Abu Dhabi, United Arab Emirates. The two sides exchanged views on the current situation in the Middle East and the Gulf region. Xi Jinping emphasised China’s principled position of persuading and promoting peace talks, and reiterated that it will continue to play a constructive role in this regard.
Financial
*The Shanghai Futures Exchange (SHFE) has announced adjustments to the price limits and margin requirements for certain futures contracts.
Apr 14 Block Trade Info
*Discount
– Wanchen Food Group (300972 CH) saw 2 block trades worth 245.54mn at 174.46yuan per share, 10.00pct discount from last closing.
– R&G Pharmastudies (301333 CH) saw 12 block trades worth 51.32mn at 63.33yuan per share, 4.38pct discount from last closing.
– Actblue (300816 CH) saw 1 block trades worth 46.34mn at 57.93yuan per share, 13.01pct discount from last closing.

For more insights, please visit Orient Futures Singapore’s research platform,
Finoview.

Disclaimer

We, Orient Futures International (Singapore) Pte. Ltd. (“OFIS”) (UEN No. 201831776Z), hold a capital markets services licence (CMS100869) from the Monetary Authority of Singapore for dealing in capital market products such as futures/derivatives contracts, and spot foreign exchange contracts for the purposes of leveraged foreign exchange trading, and is an Exempt Financial Adviser. For more information about OFIS, please visit the MAS Financial Institutions Directory.

All content, materials, information, data, statistics, features, research, documents or reports available on our website (including this article) which are financial in nature (the “Content”) are governed by our Terms of Use. By accessing, using or downloading any Content, you are deemed to have consented and agreed to the Terms of Use.

We distribute information/research (which may be prepared by us directly or produced by our foreign affiliated companies within the Orient Group of companies) pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. The information/research herein is prepared and distributed in Singapore and is intended for our clients who are Accredited Investors, Expert Investors or Institutional Investors only. If you are not an Accredited Investor, Expert Investor or Institutional Investor, you hereby acknowledge and agree that you are not the intended audience of all Content available on our website, and you undertake to immediately cease your access to any Content available on our website.

You agree to access and accept all Content available on our website on an “as-is” and “as available” basis. You agree that OFIS shall not have any responsibility or liability arising out of or in connection with, and you agree to waive the right to bring any claims or raise any complaints against OFIS in respect of any Content available on our website. OFIS shall also not be liable for any damage, loss or liability of any kind (whether actual, anticipated, consequential, special, economic or otherwise) caused as a result (direct or indirect) of the use of, or inability to access or use, the website, including but not limited to any damage, loss or liability suffered as a result of your reliance on the Content or our website.

OFIS does not make any representations, and hereby disclaim all warranties, express or implied, statutory or otherwise to the extent permitted by law, in respect of our website and all Content therein. To the fullest extent permissible, OFIS does not warrant and hereby disclaims any warranty as to the accuracy, correctness, completeness, reliability, timeliness, non-infringement, title, merchantability or fitness for any particular purpose of the Content.

All Content available on our website are general in nature and have been prepared without any consideration of your investment objectives, financial situations or needs. You should consider the appropriateness of any Content available on our website having regard to your personal circumstances before making any investment decisions. You should take into account your investment objectives and financial situation and seek advice from an independent financial advisor under a separate engagement if necessary.

Subscribe to our weekly newsletter to get the latest market news